Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	FOXO1 PARP2 REST TTF1 CLOCK CTCF H1-6 KMT2A MLLT3 NKAP NKAPL HDAC1 BAHCC1	2.56e-04	739	112	13	GO:0003682
GeneOntologyMolecularFunction	histone modifying activity	CLOCK NSD3 PHF2 EHMT1 KMT2A BRD1 HDAC1	3.11e-04	229	112	7	GO:0140993
GeneOntologyMolecularFunction	chromatin DNA binding	FOXO1 CLOCK CTCF H1-6 NKAP HDAC1	3.60e-04	167	112	6	GO:0031490
GeneOntologyMolecularFunction	histone H3K27 methyltransferase activity	NSD3 EHMT1	4.61e-04	6	112	2	GO:0046976
GeneOntologyBiologicalProcess	chromatin organization	PARP2 TOPBP1 REST TTF1 CLOCK NSD3 ZNF518A PHF2 CTCF H1-6 EHMT1 KMT2A MLLT3 BRD1 DEK HDAC1 BAHCC1	5.88e-06	896	111	17	GO:0006325
GeneOntologyBiologicalProcess	facultative heterochromatin formation	PHF2 CTCF EHMT1 KMT2A HDAC1	1.16e-05	55	111	5	GO:0140718
GeneOntologyBiologicalProcess	protein-DNA complex organization	PARP2 TOPBP1 REST TTF1 CLOCK NSD3 ZNF518A PHF2 CTCF H1-6 EHMT1 KMT2A MLLT3 BRD1 DEK HDAC1 BAHCC1	2.40e-05	999	111	17	GO:0071824
GeneOntologyBiologicalProcess	DNA methylation-dependent constitutive heterochromatin formation	CTCF EHMT1 KMT2A HDAC1	9.13e-05	44	111	4	GO:0006346
GeneOntologyCellularComponent	RQC complex	NEMF LTN1	8.51e-05	3	112	2	GO:1990112
Domain	Znf_FYVE_PHD	ING1 PCLO NSD3 PHF2 KMT2A BRD1 FGD6	2.95e-05	147	112	7	IPR011011
Domain	SynMuv_product	NKAP NKAPL	3.56e-05	2	112	2	PF06047
Domain	NKAP/UPF0396	NKAP NKAPL	3.56e-05	2	112	2	IPR009269
Domain	PHD	ING1 NSD3 PHF2 KMT2A BRD1	8.76e-05	75	112	5	PF00628
Domain	DUF4592	KIAA1210 CRACDL	1.07e-04	3	112	2	IPR028030
Domain	DUF4592	KIAA1210 CRACDL	1.07e-04	3	112	2	PF15262
Domain	Znf_PHD-finger	ING1 NSD3 PHF2 KMT2A BRD1	1.12e-04	79	112	5	IPR019787
Domain	PHD	ING1 NSD3 PHF2 KMT2A BRD1	1.97e-04	89	112	5	SM00249
Domain	PTCB-BRCT	TOPBP1 ECT2	2.12e-04	4	112	2	PF12738
Domain	Cortactin-binding_p2_N	FILIP1 CTTNBP2NL	2.12e-04	4	112	2	IPR019131
Domain	CortBP2	FILIP1 CTTNBP2NL	2.12e-04	4	112	2	PF09727
Domain	Znf_PHD	ING1 NSD3 PHF2 KMT2A BRD1	2.19e-04	91	112	5	IPR001965
Domain	ZF_PHD_2	ING1 NSD3 PHF2 KMT2A BRD1	2.67e-04	95	112	5	PS50016
Domain	PH_DOMAIN	EPS8 KIF1B DGKD ECT2 RTKN2 PLCH2 ARHGAP12 FGD6	2.79e-04	279	112	8	PS50003
Domain	ZF_PHD_1	ING1 NSD3 PHF2 KMT2A BRD1	2.81e-04	96	112	5	PS01359
Domain	PH_domain	EPS8 KIF1B DGKD ECT2 RTKN2 PLCH2 ARHGAP12 FGD6	2.86e-04	280	112	8	IPR001849
Domain	-	ING1 MYCBP2 PCLO TTC3 NSD3 PHF2 LTN1 KMT2A BRD1 FGD6	3.71e-04	449	112	10	3.30.40.10
Domain	Znf_RING/FYVE/PHD	ING1 MYCBP2 PCLO TTC3 NSD3 PHF2 LTN1 KMT2A BRD1 FGD6	4.41e-04	459	112	10	IPR013083
Domain	Haem_d1	STXBP5 KMT2A	5.26e-04	6	112	2	IPR011048
Domain	Zinc_finger_PHD-type_CS	ING1 NSD3 PHF2 BRD1	6.26e-04	65	112	4	IPR019786
Domain	Hr1	RTKN2 RHPN2	7.34e-04	7	112	2	SM00742
Domain	PH	KIF1B DGKD ECT2 RTKN2 PLCH2 ARHGAP12 FGD6	1.44e-03	278	112	7	SM00233
Domain	DAGK_acc	DGKZ DGKD	1.55e-03	10	112	2	PF00609
Domain	Diacylglycerol_kin_accessory	DGKZ DGKD	1.55e-03	10	112	2	IPR000756
Domain	DAGKa	DGKZ DGKD	1.55e-03	10	112	2	SM00045
Domain	SET	NSD3 EHMT1 KMT2A	1.90e-03	41	112	3	PF00856
Domain	ABC_A	ABCA9 ABCA6	2.26e-03	12	112	2	IPR026082
Domain	-	EPS8 KIF1B DGKD ECT2 RTKN2 PLCH2 ARHGAP12 FGD6	2.46e-03	391	112	8	2.30.29.30
Domain	PH	KIF1B DGKD RTKN2 PLCH2 ARHGAP12 FGD6	2.59e-03	229	112	6	PF00169
Domain	SET	NSD3 EHMT1 KMT2A	2.64e-03	46	112	3	SM00317
Domain	ABC_tran	ABCA9 ABCB4 ABCA6	2.98e-03	48	112	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCA9 ABCB4 ABCA6	2.98e-03	48	112	3	PS50893
Domain	DAGKc	DGKZ DGKD	3.09e-03	14	112	2	SM00046
Domain	ABC_TRANSPORTER_1	ABCA9 ABCB4 ABCA6	3.16e-03	49	112	3	PS00211
Domain	SET_dom	NSD3 EHMT1 KMT2A	3.35e-03	50	112	3	IPR001214
Domain	SET	NSD3 EHMT1 KMT2A	3.35e-03	50	112	3	PS50280
Domain	ABC_transporter-like	ABCA9 ABCB4 ABCA6	3.35e-03	50	112	3	IPR003439
Domain	Diacylglycerol_kinase_cat_dom	DGKZ DGKD	3.56e-03	15	112	2	IPR001206
Domain	DAGK_cat	DGKZ DGKD	3.56e-03	15	112	2	PF00781
Domain	DAGK	DGKZ DGKD	3.56e-03	15	112	2	PS50146
Domain	zf-RING_2	MYCBP2 TTC3 LTN1	3.75e-03	52	112	3	PF13639
Domain	Post-SET_dom	NSD3 KMT2A	4.05e-03	16	112	2	IPR003616
Domain	PostSET	NSD3 KMT2A	4.05e-03	16	112	2	SM00508
Domain	POST_SET	NSD3 KMT2A	4.05e-03	16	112	2	PS50868
Domain	PH_dom-like	EPS8 KIF1B DGKD ECT2 RTKN2 PLCH2 ARHGAP12 FGD6	4.14e-03	426	112	8	IPR011993
Domain	NAD/diacylglycerol_kinase	DGKZ DGKD	4.57e-03	17	112	2	IPR016064
Domain	C1_1	DGKZ DGKD STAC	4.85e-03	57	112	3	PF00130
Domain	BRCT	TOPBP1 ECT2	5.70e-03	19	112	2	PF00533
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	REST NSD3 PHF2 EHMT1 KMT2A BRD1 HDAC1	3.60e-05	175	74	7	MM14941
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	FOXO1 TOPBP1 SRSF11 UPF3B TTF1 ZKSCAN5 SRRT CTCF EHMT1 KMT2A MLLT3 BOD1L1 BRD1 DEK PLK3 HDAC1	6.36e-05	1022	74	16	MM15436
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	REST CLOCK NSD3 PHF2 EHMT1 KMT2A BRD1 HDAC1	8.68e-05	272	74	8	M29619
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	EPS8 SETX CCDC137 ATAD5 PARP2 HMGXB4 TOPBP1 DGKZ LYAR ECT2 TTF1 CTTNBP2NL NSD3 PHF2 SRRT CTCF PA2G4 CRACDL EIF4B LTN1 EHMT1 KMT2A UTP20 AFDN NKAP FKBP3 C8orf33 MARCKS RBFA HDAC1	1.15e-15	1497	116	30	31527615
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL24 SETX ING1 ATAD5 PARP2 HMGXB4 TOPBP1 SRSF11 REST LYAR TTF1 CLOCK NSD3 PHF2 SRRT PPIG CTCF DDX18 H1-6 EHMT1 KMT2A UTP20 ELF4 DEK RPL6 HDAC1	1.22e-13	1294	116	26	30804502
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	CCDC137 MYCBP2 ATAD5 TOPBP1 UPF3B LYAR ECT2 TTF1 SRRT PA2G4 DDX18 NEMF UTP20 NKAP DEK FKBP3 RPL6 C8orf33 LRRFIP1 HDAC1	9.28e-13	759	116	20	35915203
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RBM11 SETX CCDC137 ING1 ATAD5 HMGXB4 TOPBP1 SRSF11 LYAR NSD3 PHF2 SRRT CTCF PA2G4 DDX18 EIF4B KMT2A AFDN BOD1L1 DEK FKBP3	7.05e-12	954	116	21	36373674
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	FOXO1 SETX MYCBP2 KIF1B MAP3K14 SRSF11 ECT2 CDC14A NSD3 FSIP2 SRRT ALMS1 CLMN EIF4B KMT2A AFDN BOD1L1 BRD1 FGD6	7.56e-11	861	116	19	36931259
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	RPL24 CCDC137 MYCBP2 KIF1B LYAR SRRT PA2G4 DDX18 EIF4B BOD1L1 FKBP3 RPL6 C8orf33 MARCKS RBFA LRRFIP1 HDAC1	1.73e-09	809	116	17	32129710
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	RBM11 SETX ATAD5 HMGXB4 TOPBP1 LYAR NSD3 PHF2 FSIP2 EHMT1 KMT2A BOD1L1 BRD1 DEK HDAC1	1.99e-09	608	116	15	36089195
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RPL24 RBM11 CDV3 ATAD5 UPF3B SNX29 FAM193A ALMS1 CTCF PA2G4 CLMN EIF4B KMT2A BOD1L1 SMCR8 FKBP3 RPL6 MARCKS	2.13e-09	934	116	18	33916271
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	RPL24 SETX MYCBP2 HMGXB4 SRSF11 LYAR NSD3 PHF2 SRRT PPIG DDX18 NEMF EHMT1 NKAPL DEK FKBP3 RPL6 MARCKS	2.06e-08	1082	116	18	38697112
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	RPL24 CDV3 LYAR SRRT DDX18 H1-6 KMT2A AFDN DDX60L DEK FKBP3 RPL6 ACSL5 HDAC1	1.16e-07	711	116	14	33022573
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SETX SRSF11 UPF3B LYAR TTF1 PHF2 SRRT PPIG CTCF PA2G4 DDX18 NEMF KMT2A NKAP DEK FKBP3 C8orf33 MARCKS LRRFIP1	1.41e-07	1371	116	19	36244648
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	CCDC137 LYAR CTCF DDX18 NEMF UTP20 DDX60L BRD1 C8orf33 LRRFIP1	1.83e-07	332	116	10	25693804
Pubmed	Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.	PARP2 TOPBP1 CLOCK CTCF EHMT1 HDAC1	2.36e-07	77	116	6	19505873
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPL24 PCLO UPF3B LYAR TTC3 PHF2 SRRT PA2G4 DDX18 NEMF EHMT1 UTP20 AFDN BOD1L1 DEK FKBP3 RPL6 MARCKS HDAC1	2.55e-07	1425	116	19	30948266
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FILIP1 MYCBP2 KIF1B REST CTTNBP2NL SRRT PPIG EIF4B KMT2A UTP20 AFDN NKAP MRTFA LRRFIP1	3.25e-07	774	116	14	15302935
Pubmed	[Application of reverse transcription-multiplex nested PCR to detect MLL rearrangement in AML-M4/M5].	KMT2A MLLT3 AFDN	3.60e-07	5	116	3	16086288
Pubmed	Identification of candidate substrates for poly(ADP-ribose) polymerase-2 (PARP2) in the absence of DNA damage using high-density protein microarrays.	PARP2 STAC FKBP3	3.60e-07	5	116	3	21812934
Pubmed	USP7 Deubiquitinates and Stabilizes SIRT1.	TOPBP1 ECT2 HDAC1	7.18e-07	6	116	3	31502386
Pubmed	The ribosome quality control pathway can access nascent polypeptides stalled at the Sec61 translocon.	NEMF LTN1 RPL6	7.18e-07	6	116	3	25877867
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	RPL24 CCDC137 SRSF11 UPF3B LYAR SRRT PPIG DDX18 LTN1 NKAP DEK RPL6 C8orf33	8.05e-07	713	116	13	29802200
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ATAD5 HMGXB4 LYAR ZKSCAN5 NSD3 ZNF518A PHF2 ALMS1 CTCF DDX18 LTN1 EHMT1 NKAP BRD1 HDAC1 BAHCC1	9.75e-07	1116	116	16	31753913
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	RPL24 RBM11 CCDC137 SRSF11 LYAR SRRT PPIG PA2G4 DDX18 NKAP DEK RPL6 C8orf33	1.06e-06	731	116	13	29298432
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CYLC1 PCLO BIVM SANBR SRSF11 MYNN TTC3 ABCB4 EIF4B ARHGAP12 H1-6 KMT2A BOD1L1 RPL6 RBFA HDAC1 BAHCC1 MYBPC2	1.40e-06	1442	116	18	35575683
Pubmed	ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.	LYAR PPIG CTCF DDX18 EHMT1 BRD1 RPL6 MARCKS HDAC1	1.75e-06	330	116	9	33301849
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	RPL24 SRSF11 LYAR PPIG FAM193A CTCF DDX18 UTP20 NKAP RPL6 C8orf33 HDAC1	2.08e-06	655	116	12	35819319
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SETX ING1 UPF3B REST LYAR ALMS1 EHMT1 KMT2A BOD1L1 DEK	4.12e-06	469	116	10	27634302
Pubmed	CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation.	REST EHMT1 HDAC1	4.26e-06	10	116	3	19061646
Pubmed	Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes.	RPL24 NEXMIF REST ZNF518A EHMT1	5.07e-06	74	116	5	29795351
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RPL24 CCDC137 SRSF11 LYAR NSD3 CTCF DDX18 EHMT1 KMT2A UTP20 DEK RPL6 HDAC1	5.30e-06	847	116	13	35850772
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	RPL24 CCDC137 UPF3B LYAR ECT2 CTCF DDX18 UTP20 RPL6 HDAC1	5.34e-06	483	116	10	36912080
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	RPL24 PARP2 SRSF11 LYAR ECT2 SRRT CD2 CTCF DDX18 EIF4B UTP20 BOD1L1 DEK RPL6	5.68e-06	989	116	14	36424410
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	RPL24 CCDC137 ATAD5 LYAR SRRT DDX18 KMT2A BRD1 DEK RPL6 HDAC1	6.10e-06	605	116	11	28977666
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ATAD5 LYAR NSD3 SRRT PPIG CTCF PA2G4 DDX18 EHMT1 KMT2A BOD1L1 DEK FKBP3 HDAC1	7.53e-06	1014	116	14	32416067
Pubmed	MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.	KMT2A MLLT3	1.10e-05	2	116	2	27344946
Pubmed	Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases.	KMT2A MLLT3	1.10e-05	2	116	2	20395514
Pubmed	Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.	KMT2A MLLT3	1.10e-05	2	116	2	32768438
Pubmed	Structure and assembly pathway of the ribosome quality control complex.	NEMF LTN1	1.10e-05	2	116	2	25578875
Pubmed	Impact of MLL::AF9 Gene Rearrangement on Survival of Acute Myeloid Leukaemia Patients: An Insight into Pakistani Population.	KMT2A MLLT3	1.10e-05	2	116	2	38576284
Pubmed	MLL-AF9 regulates transcriptional initiation in mixed lineage leukemic cells.	KMT2A MLLT3	1.10e-05	2	116	2	39002676
Pubmed	Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia.	KMT2A MLLT3	1.10e-05	2	116	2	21959947
Pubmed	MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny.	KMT2A MLLT3	1.10e-05	2	116	2	23178754
Pubmed	Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.	CTCF KMT2A	1.10e-05	2	116	2	34405474
Pubmed	Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development.	KMT2A MLLT3	1.10e-05	2	116	2	11265751
Pubmed	MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia.	KMT2A AFDN	1.10e-05	2	116	2	24695851
Pubmed	Dysregulation of ribosome-associated quality control elicits cognitive disorders via overaccumulation of TTC3.	TTC3 LTN1	1.10e-05	2	116	2	36917672
Pubmed	MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer.	NKAP MARCKS	1.10e-05	2	116	2	33754052
Pubmed	An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model.	KMT2A MLLT3	1.10e-05	2	116	2	22427200
Pubmed	NRSF/REST lies at the intersection between epigenetic regulation, miRNA-mediated gene control and neurodevelopmental pathways associated with Intellectual disability (ID) and Schizophrenia.	REST EHMT1	1.10e-05	2	116	2	36216811
Pubmed	Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.	KMT2A MLLT3	1.10e-05	2	116	2	30387535
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	RBM11 MYCBP2 ATAD5 PARP2 TOPBP1 UPF3B NSD3 PHF2 ALMS1 KMT2A BRD1	1.11e-05	645	116	11	25281560
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	SETX SLCO3A1 SRSF11 ARMCX5 CDC14A SNX29 EIF4B RPL6 HDAC1	1.22e-05	420	116	9	28065597
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	RPL24 CCDC137 SRSF11 UPF3B LYAR SRRT PPIG DDX18 EIF4B UTP20 NKAP DEK	1.70e-05	807	116	12	22681889
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	RPL24 CCDC137 SRSF11 UPF3B LYAR FAM193A DDX18 EIF4B SECISBP2 NKAP C8orf33	1.76e-05	678	116	11	30209976
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RPL24 CCDC137 PARP2 UPF3B LYAR ECT2 DDX18 EIF4B UTP20 DEK RPL6 LRRFIP1 HDAC1	1.77e-05	949	116	13	36574265
Pubmed	A protein-RNA interaction atlas of the ribosome biogenesis factor AATF.	SRRT PA2G4 DDX18 EIF4B UTP20 RPL6	1.81e-05	162	116	6	31363146
Pubmed	A bead-based approach for large-scale identification of in vitro kinase substrates.	SRSF11 SRRT EIF4B DEK RPL6 HDAC1	1.87e-05	163	116	6	22113938
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RPL24 PARP2 LYAR ECT2 NSD3 SRRT PA2G4 DDX18 EIF4B UTP20 FKBP3 RPL6 MARCKS LRRFIP1 HDAC1	1.95e-05	1257	116	15	36526897
Pubmed	The protein composition of mitotic chromosomes determined using multiclassifier combinatorial proteomics.	CCDC137 PHF2 DDX18	2.38e-05	17	116	3	20813266
Pubmed	Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.	FOXO1 MARCKS HDAC1	2.38e-05	17	116	3	17322895
Pubmed	Inhibition of a transcriptional repressor rescues hearing in a splicing factor-deficient mouse.	KIF1B REST SRRM3	2.84e-05	18	116	3	33087486
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	FOXO1 EPS8 RBM11 GRIPAP1 SETX KIF1B TOPBP1 UPF3B ALMS1 SECISBP2	2.90e-05	588	116	10	38580884
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	EPS8 GRIPAP1 CDV3 STXBP5 KIF1B LYAR PPIG ALMS1 EIF4B ARHGAP12 AFDN NKAP	2.93e-05	853	116	12	28718761
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MYCBP2 HMGXB4 SRSF11 UPF3B ECT2 PPIG EIF4B NKAP	2.99e-05	361	116	8	26167880
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CDV3 MYCBP2 ATAD5 TTC3 FAM193A DDX18 EIF4B EHMT1 SECISBP2 FKBP3 LRRFIP1	3.20e-05	724	116	11	36232890
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	RPL24 EPS8 SRRT FAM193A PA2G4 CLMN ARHGAP12 NEMF FKBP3	3.21e-05	475	116	9	31040226
Pubmed	Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes.	REST HDAC1	3.30e-05	3	116	2	10491605
Pubmed	Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.	FOXO1 PIK3CD	3.30e-05	3	116	2	28710412
Pubmed	Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23).	KMT2A MLLT3	3.30e-05	3	116	2	16328057
Pubmed	CTCF regulates the FoxO signaling pathway to affect the progression of prostate cancer.	FOXO1 CTCF	3.30e-05	3	116	2	30873749
Pubmed	Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death.	KMT2A MLLT3	3.30e-05	3	116	2	23624644
Pubmed	Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.	KMT2A AFDN	3.30e-05	3	116	2	23361907
Pubmed	Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells.	REST HDAC1	3.30e-05	3	116	2	15897453
Pubmed	FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat.	FKBP3 HDAC1	3.30e-05	3	116	2	34281390
Pubmed	CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.	KMT2A MLLT3	3.30e-05	3	116	2	32549410
Pubmed	FLT3N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis.	KMT2A MLLT3	3.30e-05	3	116	2	30953031
Pubmed	Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.	KMT2A MLLT3	3.30e-05	3	116	2	18538732
Pubmed	Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.	KMT2A MRTFA	3.30e-05	3	116	2	28063190
Pubmed	The histone methyltransferase activity of WHISTLE is important for the induction of apoptosis and HDAC1-mediated transcriptional repression.	NSD3 HDAC1	3.30e-05	3	116	2	17239852
Pubmed	The uncharacterized SANT and BTB domain-containing protein SANBR inhibits class switch recombination.	SANBR HDAC1	3.30e-05	3	116	2	33831416
Pubmed	High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.	KMT2A MLLT3	3.30e-05	3	116	2	21937695
Pubmed	The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.	KMT2A AFDN	3.30e-05	3	116	2	16239140
Pubmed	FoxO regulates expression of ABCA6, an intracellular ATP-binding-cassette transporter responsive to cholesterol.	FOXO1 ABCA6	3.30e-05	3	116	2	24028821
Pubmed	The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes.	KMT2A MLLT3	3.30e-05	3	116	2	36358022
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	RPL24 PARP2 SRSF11 LYAR TTF1 PHF2 PPIG PA2G4 DDX18 H1-6 KMT2A NKAP DEK RPL6 HDAC1	3.37e-05	1318	116	15	30463901
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	SRSF11 PPIG DDX18 NKAP DEK RPL6 LRRFIP1	3.48e-05	269	116	7	29511261
Pubmed	Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.	HMGXB4 TTF1 PHF2 DDX18	3.77e-05	56	116	4	26919559
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	ING1 MYNN REST CLOCK ZKSCAN5 PHF2 PA2G4 EHMT1 BRD1 DEK MRTFA HDAC1	3.83e-05	877	116	12	20211142
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	FOXO1 RPL24 DGKZ UPF3B SRRT BTBD7 EIF4B ARHGAP12 MLLT3 DEK RPL6 MRTFA GAREM1	4.46e-05	1038	116	13	26673895
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPL24 SETX DIS3L2 MYCBP2 DGKD LYAR ECT2 SRRT PA2G4 DDX18 LTN1 UTP20 AFDN DDX60L RPL6	4.54e-05	1353	116	15	29467282
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYCBP2 KIF1B DGKD TTC3 ECT2 ALMS1 CLMN EIF4B MYBPC2	4.56e-05	497	116	9	23414517
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	SETX TOPBP1 ECT2 CTTNBP2NL SRRT PA2G4 AFDN MRTFA LRRFIP1	5.00e-05	503	116	9	16964243
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	ATAD5 PARP2 LYAR NSD3 CTCF DDX18 KMT2A HDAC1	5.54e-05	394	116	8	27248496
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	CCDC168 TTF1 FSIP2 ELF4 NKAP	5.98e-05	123	116	5	26912792
Pubmed	Relationships between AML1-ETO and MLL-AF9 fusion gene expressions and hematological parameters in acute myeloid leukemia.	KMT2A MLLT3	6.59e-05	4	116	2	33431365
Pubmed	Polycomb repressive complex 2 is required for MLL-AF9 leukemia.	KMT2A MLLT3	6.59e-05	4	116	2	22396593
Pubmed	The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia.	KMT2A MLLT3	6.59e-05	4	116	2	22469984
Pubmed	MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors.	KMT2A MLLT3	6.59e-05	4	116	2	31852898
Pubmed	Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.	KMT2A MLLT3	6.59e-05	4	116	2	27607576
Pubmed	DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.	KMT2A MLLT3	6.59e-05	4	116	2	21521783
Pubmed	PHF2 regulates sarcomeric gene transcription in myogenesis.	PHF2 MYBPC2	6.59e-05	4	116	2	38701072
Interaction	RPS24 interactions	RPL24 CCDC137 ATAD5 NEIL1 MAP3K14 CCDC168 UPF3B REST LYAR ECT2 PHF2 CTCF DDX18 EIF4B H1-6 UTP20 RPL6	8.38e-09	529	115	17	int:RPS24
Interaction	H2BC21 interactions	CYLC1 GOLGA6L2 ATAD5 PCLO PARP2 HMGXB4 REST TTF1 NSD3 PHF2 H1-6 EHMT1 KMT2A DDX60L BRD1 DEK C8orf33 HDAC1 BAHCC1	1.44e-08	696	115	19	int:H2BC21
Interaction	NUP43 interactions	RBM11 SETX TOPBP1 CCDC168 TTF1 NSD3 ZNF518A PHF2 FSIP2 SRRT CTCF DDX18 EHMT1 KMT2A UTP20 ELF4 BOD1L1 NKAP	1.59e-08	625	115	18	int:NUP43
Interaction	NOP56 interactions	RPL24 RBM11 CCDC137 ATAD5 NEIL1 LYAR ECT2 TTF1 PHF2 CTCF DDX18 NEMF UTP20 NKAP DEK RPL6 C8orf33	2.51e-08	570	115	17	int:NOP56
Interaction	LYAR interactions	FOXO1 CCDC137 REST LYAR ECT2 TTF1 CD2 CTCF DDX18 H1-6 NKAP BRD1 RPL6 C8orf33	2.85e-08	373	115	14	int:LYAR
Interaction	CENPA interactions	RBM11 ATAD5 PARP2 HMGXB4 LYAR NSD3 PHF2 SRRT DDX18 EHMT1 KMT2A UTP20 DEK HDAC1	3.25e-08	377	115	14	int:CENPA
Interaction	SMC5 interactions	RBM11 SETX CCDC137 ING1 ATAD5 HMGXB4 TOPBP1 SRSF11 LYAR NSD3 PHF2 SRRT CTCF PA2G4 DDX18 EIF4B KMT2A AFDN BOD1L1 DEK FKBP3	2.04e-07	1000	115	21	int:SMC5
Interaction	NPM1 interactions	RPL24 FILIP1 RBM11 CCDC137 PARP2 SRSF11 REST LYAR ECT2 TTF1 CDC14A SRRT CTCF PA2G4 DDX18 LTN1 KMT2A ELF4 BRD1 FGD6 RPL6 C8orf33 HDAC1	2.53e-07	1201	115	23	int:NPM1
Interaction	ZNF330 interactions	CCDC137 ATAD5 HMGXB4 TOPBP1 LYAR NSD3 PHF2 DDX18 EHMT1 KMT2A UTP20 BRD1 DEK RPL6	2.56e-07	446	115	14	int:ZNF330
Interaction	RPL18A interactions	RPL24 CCDC137 MAP3K14 REST LYAR ECT2 TTF1 PHF2 CTCF PA2G4 DDX18 RPL6 C8orf33 MARCKS	2.64e-07	447	115	14	int:RPL18A
Interaction	RPL31 interactions	FOXO1 RPL24 CCDC137 ATAD5 UPF3B REST LYAR ECT2 TTF1 NSD3 PHF2 CTCF DDX18 EIF4B H1-6 UTP20 RPL6	3.12e-07	680	115	17	int:RPL31
Interaction	SRPK2 interactions	CCDC137 MYCBP2 NEIL1 HMGXB4 SRSF11 UPF3B LYAR ECT2 SRRT PPIG ALMS1 CTCF DDX18 EIF4B ARHGAP12 NKAP C8orf33	6.53e-07	717	115	17	int:SRPK2
Interaction	HECTD1 interactions	CCDC137 MYCBP2 ATAD5 TOPBP1 UPF3B LYAR ECT2 TTF1 SRRT PA2G4 DDX18 NEMF UTP20 NKAP DEK FKBP3 RPL6 C8orf33 LRRFIP1 HDAC1	6.92e-07	984	115	20	int:HECTD1
Interaction	POLR1G interactions	FOXO1 ATAD5 TOPBP1 LYAR TTF1 NSD3 PHF2 CTCF DDX18 EHMT1 KMT2A UTP20 RPL6 HDAC1	7.73e-07	489	115	14	int:POLR1G
Interaction	POLR1E interactions	RBM11 ATAD5 NEIL1 LYAR TTF1 PHF2 CTCF DDX18 EHMT1 KMT2A UTP20 HDAC1	7.74e-07	350	115	12	int:POLR1E
Interaction	RPL10A interactions	RPL24 CCDC137 NEIL1 MAP3K14 REST LYAR ECT2 TTF1 CTCF DDX18 EIF4B H1-6 RPL6 C8orf33	7.92e-07	490	115	14	int:RPL10A
Interaction	H3C3 interactions	SETX ATAD5 HMGXB4 TOPBP1 LYAR NSD3 PHF2 FSIP2 EHMT1 KMT2A BOD1L1 BRD1 DEK HDAC1	8.93e-07	495	115	14	int:H3C3
Interaction	H3-3A interactions	RBM11 ATAD5 PARP2 HMGXB4 TOPBP1 LYAR NSD3 PHF2 H1-6 EHMT1 KMT2A MLLT3 BOD1L1 BRD1 DEK LRRFIP1 HDAC1	1.19e-06	749	115	17	int:H3-3A
Interaction	RPL23A interactions	FOXO1 RPL24 CCDC137 NEIL1 REST LYAR ECT2 TTF1 CTCF PA2G4 DDX18 EIF4B KMT2A RPL6 C8orf33	1.87e-06	606	115	15	int:RPL23A
Interaction	RPS6 interactions	RPL24 CCDC137 PCLO UPF3B REST LYAR ECT2 TTF1 NSD3 PHF2 CTCF PA2G4 DDX18 EIF4B UTP20 DEK RPL6 C8orf33	2.23e-06	874	115	18	int:RPS6
Interaction	NAA40 interactions	RPL24 RBM11 CDV3 ATAD5 PARP2 UPF3B SNX29 FAM193A ALMS1 CTCF PA2G4 CLMN EIF4B KMT2A BOD1L1 SMCR8 FKBP3 RPL6 MARCKS	2.65e-06	978	115	19	int:NAA40
Interaction	RPS27L interactions	RPL24 MAP3K14 REST ECT2 CTCF PA2G4 LTN1 RPL6 HDAC1	2.82e-06	206	115	9	int:RPS27L
Interaction	RPL30 interactions	RPL24 CCDC137 MAP3K14 REST LYAR TTF1 NSD3 CTCF PA2G4 NEMF H1-6 RPL6 C8orf33	3.16e-06	474	115	13	int:RPL30
Interaction	BRD3 interactions	ATAD5 HMGXB4 LYAR ZKSCAN5 NSD3 ZNF518A PHF2 CTCF DDX18 EHMT1 KMT2A NKAP DEK	4.95e-06	494	115	13	int:BRD3
Interaction	H2BC8 interactions	ATAD5 PARP2 HMGXB4 TOPBP1 UPF3B LYAR NSD3 EPG5 PHF2 CTCF EHMT1 KMT2A BRD1 DEK	5.21e-06	576	115	14	int:H2BC8
Interaction	RPLP0 interactions	RPL24 DIS3L2 CCDC137 NEIL1 REST LYAR ECT2 TTF1 CTCF PA2G4 DDX18 KMT2A RPL6 C8orf33 LRRFIP1	5.28e-06	660	115	15	int:RPLP0
Interaction	ZNF668 interactions	CCDC137 NEIL1 LYAR TTF1 CTCF DDX18 H1-6 RPL6 C8orf33	6.01e-06	226	115	9	int:ZNF668
Interaction	SRSF6 interactions	RPL24 DIS3L2 CCDC137 SRSF11 REST ECT2 TTF1 SRRT PPIG CTCF DDX18 H1-6 KMT2A	6.01e-06	503	115	13	int:SRSF6
Interaction	BRD2 interactions	ATAD5 HMGXB4 TOPBP1 LYAR NSD3 ZNF518A PHF2 CTCF DDX18 EHMT1 NKAP DEK	6.34e-06	429	115	12	int:BRD2
Interaction	H1-1 interactions	CCDC137 PCLO LYAR ECT2 TTF1 NSD3 CTCF PA2G4 DDX18 H1-6 DEK RPL6 HDAC1	6.54e-06	507	115	13	int:H1-1
Interaction	NCL interactions	FOXO1 RPL24 NEIL1 REST LYAR ECT2 PPIG CTCF PA2G4 BTBD7 DDX18 EIF4B KMT2A DEK PPP1R42 RPL6	1.21e-05	798	115	16	int:NCL
Interaction	SRPK3 interactions	CCDC137 SRSF11 LYAR TTC3 TTF1 SRRT DDX18 H1-6	1.35e-05	190	115	8	int:SRPK3
Interaction	DDX21 interactions	FOXO1 CCDC137 NEIL1 SANBR REST LYAR ECT2 SRRT CTCF PA2G4 DDX18 H1-6 DEK RPL6 C8orf33	1.44e-05	718	115	15	int:DDX21
Interaction	RPL3 interactions	RPL24 CCDC137 NEIL1 MAP3K14 REST LYAR ECT2 TTF1 CTCF PA2G4 DDX18 H1-6 KMT2A RPL6 C8orf33	1.53e-05	722	115	15	int:RPL3
Interaction	RPL14 interactions	RPL24 CCDC137 MAP3K14 REST ECT2 TTF1 PPIG CTCF DDX18 EIF4B H1-6 RPL6 C8orf33	1.68e-05	554	115	13	int:RPL14
Interaction	SRSF5 interactions	CCDC137 NEIL1 MAP3K14 REST LYAR ECT2 TTF1 PPIG CTCF DDX18 KMT2A RPL6	1.72e-05	474	115	12	int:SRSF5
Interaction	SPANXN2 interactions	MYCBP2 BIVM TTC3 ECT2 ALMS1 NEMF	1.74e-05	95	115	6	int:SPANXN2
Interaction	RRP8 interactions	CCDC137 NEIL1 MAP3K14 IMPACT DGKZ LYAR ECT2 H1-6 C8orf33	1.79e-05	259	115	9	int:RRP8
Interaction	SRPK1 interactions	MAP3K14 SANBR SRSF11 LYAR ECT2 PPIG CTCF DDX18 ARHGAP12 NKAP FKBP3 PLK3	1.83e-05	477	115	12	int:SRPK1
Interaction	PRKRA interactions	RPL24 CCDC137 NEIL1 MAP3K14 LYAR TTF1 CTCF DDX18 KMT2A RPL6 C8orf33	1.84e-05	400	115	11	int:PRKRA
Interaction	CIT interactions	RPL24 SETX STXBP5 PCLO UPF3B LYAR TTC3 ECT2 PHF2 ALMS1 PA2G4 DDX18 H1-6 KMT2A SECISBP2 UTP20 BOD1L1 DDX60L NKAPL DEK RPL6 HDAC1	2.09e-05	1450	115	22	int:CIT
Interaction	RPL11 interactions	RPL24 CCDC137 NEIL1 REST LYAR ECT2 TTF1 CTCF PA2G4 DDX18 NEMF H1-6 RPL6 C8orf33	2.10e-05	652	115	14	int:RPL11
Interaction	SIRT1 interactions	FOXO1 ING1 TOPBP1 ECT2 CLOCK MLLT3 BRD1 RPL6 RBFA LRRFIP1 HDAC1	2.42e-05	412	115	11	int:SIRT1
Interaction	LRRFIP1 interactions	FOXO1 MYCBP2 CTCF DEK FKBP3 LRRFIP1 HDAC1	2.80e-05	153	115	7	int:LRRFIP1
Interaction	FTL interactions	KIF1B DGKZ ARMCX5 LYAR ECT2 ZNF518A PHF2 ALMS1 NKAP SMCR8	3.10e-05	348	115	10	int:FTL
Interaction	MAGEB2 interactions	CCDC137 LYAR TTF1 PPIG CTCF DDX18 H1-6 RPL6 C8orf33 HDAC1	3.18e-05	349	115	10	int:MAGEB2
Interaction	SURF6 interactions	CCDC137 NEIL1 PARP2 MAP3K14 IMPACT LYAR TTF1 CTCF DDX18 RPL6 C8orf33	3.28e-05	426	115	11	int:SURF6
Interaction	RPL13A interactions	RPL24 CCDC137 MAP3K14 REST LYAR ECT2 TTF1 CTCF DDX18 EIF4B KMT2A BOD1L1 RPL6	3.29e-05	591	115	13	int:RPL13A
Interaction	NOC2L interactions	CCDC137 NEIL1 MAP3K14 DGKZ LYAR DDX18 ARHGAP12 H1-6 MARCKS	3.49e-05	282	115	9	int:NOC2L
Interaction	MECP2 interactions	RPL24 SETX MYCBP2 HMGXB4 SRSF11 LYAR NSD3 PHF2 SRRT PPIG DDX18 NEMF H1-6 EHMT1 NKAPL DEK FKBP3 RPL6 MARCKS HDAC1	3.77e-05	1287	115	20	int:MECP2
Interaction	ZC3H18 interactions	RPL24 RBM11 CCDC137 NEIL1 SRSF11 LYAR SRRT PPIG CTCF PA2G4 DDX18 NKAP BRD1 DEK RPL6 C8orf33	3.82e-05	877	115	16	int:ZC3H18
Interaction	DST interactions	RBM11 MYCBP2 TTC3 ECT2 CLMN AFDN RPL6 HDAC1 MYBPC2	4.00e-05	287	115	9	int:DST
Interaction	RPL5 interactions	RPL24 CCDC137 MAP3K14 REST LYAR ECT2 CTCF PA2G4 DDX18 EIF4B NEMF RPL6 MARCKS	4.26e-05	606	115	13	int:RPL5
Interaction	RPL13 interactions	RPL24 GRIPAP1 CCDC137 MAP3K14 REST LYAR ECT2 TTF1 CDC14A CTCF DDX18 KMT2A RPL6 C8orf33	4.56e-05	700	115	14	int:RPL13
Interaction	WDR5 interactions	RPL24 CDV3 LYAR ECT2 SRRT CTCF DDX18 H1-6 KMT2A AFDN BOD1L1 DDX60L DEK FKBP3 RPL6 MARCKS ACSL5 HDAC1	5.06e-05	1101	115	18	int:WDR5
Interaction	YWHAH interactions	FOXO1 SETX ING1 MYCBP2 KIF1B ECT2 CDC14A NSD3 SRRT ALMS1 RHPN2 CLMN EIF4B KMT2A AFDN BOD1L1 BRD1 FGD6	5.12e-05	1102	115	18	int:YWHAH
Interaction	H1-6 interactions	CCDC137 NEIL1 LYAR ECT2 TTF1 H1-6 NKAP RPL6	5.12e-05	229	115	8	int:H1-6
Interaction	IFI16 interactions	CCDC137 SRSF11 UPF3B LYAR CTCF DDX18 EIF4B NEMF UTP20 DDX60L BRD1 RPL6 C8orf33 LRRFIP1	5.64e-05	714	115	14	int:IFI16
Interaction	RPL8 interactions	RPL24 CCDC137 NEIL1 MAP3K14 REST ECT2 TTF1 CTCF PA2G4 DDX18 RPL6 C8orf33	6.00e-05	539	115	12	int:RPL8
Interaction	FBL interactions	NEIL1 MAP3K14 UPF3B REST LYAR ECT2 CTCF DDX18 SECISBP2 UTP20 BRD1 FKBP3 RPL6	7.30e-05	639	115	13	int:FBL
Interaction	RPS19 interactions	RPL24 CCDC137 REST LYAR ECT2 TTF1 CTCF DDX18 EIF4B H1-6 EHMT1 RPL6 HDAC1	7.30e-05	639	115	13	int:RPS19
Interaction	RPS7 interactions	FOXO1 RPL24 UPF3B REST ECT2 CTCF DDX18 EIF4B NEMF UTP20 RPL6	7.36e-05	466	115	11	int:RPS7
Interaction	RPL37A interactions	RPL24 CCDC137 NEIL1 MAP3K14 REST LYAR TTF1 CTCF DEK RPL6	8.23e-05	391	115	10	int:RPL37A
Interaction	RPL9 interactions	RPL24 NEIL1 MAP3K14 REST ECT2 CTCF PA2G4 DDX18 EIF4B RPL6	9.52e-05	398	115	10	int:RPL9
Interaction	CSNK2A1 interactions	ATAD5 NEIL1 KIF1B DGKZ SRSF11 UPF3B SRRT EIF4B EHMT1 KMT2A NKAP DEK FKBP3 RPL6 MARCKS HDAC1	1.05e-04	956	115	16	int:CSNK2A1
Interaction	FKBP3 interactions	FSIP2 FKBP3 MARCKS LRRFIP1 HDAC1 GAREM1	1.06e-04	131	115	6	int:FKBP3
Interaction	DIMT1 interactions	RPL24 CDC14A PA2G4 NEMF LTN1 BRD1 FKBP3	1.07e-04	189	115	7	int:DIMT1
Interaction	NKAP interactions	UPF3B LYAR PPIG H1-6 NKAP NKAPL	1.11e-04	132	115	6	int:NKAP
Interaction	H2BC4 interactions	RPL24 PARP2 UPF3B FSIP2 EIF4B H1-6 KMT2A LRRFIP1	1.21e-04	259	115	8	int:H2BC4
Interaction	RCOR1 interactions	RBM11 GRIPAP1 MYCBP2 REST CLOCK FAM193A ALMS1 EHMT1 MRTFA LRRFIP1 HDAC1	1.23e-04	494	115	11	int:RCOR1
Interaction	SNRNP70 interactions	RPL24 RBM11 CCDC137 SRSF11 UPF3B LYAR ECT2 SRRT PPIG DDX18 LTN1 NKAP DEK RPL6 C8orf33 HDAC1	1.47e-04	984	115	16	int:SNRNP70
Interaction	RPS11 interactions	RPL24 CCDC137 MAP3K14 REST ECT2 PPIG CTCF EIF4B BRD1 RPL6 HDAC1	1.49e-04	505	115	11	int:RPS11
Interaction	PFN1 interactions	RBM11 PCLO UPF3B CTTNBP2NL PPIG ALMS1 AFDN BOD1L1 FKBP3 MARCKS MRTFA	1.60e-04	509	115	11	int:PFN1
Interaction	RNF113A interactions	RPL24 SRSF11 LYAR PPIG FAM193A CTCF DDX18 EIF4B UTP20 NKAP RPL6 C8orf33 HDAC1	1.61e-04	692	115	13	int:RNF113A
Interaction	KAT6A interactions	RPL24 CCDC137 UPF3B CTCF EIF4B KMT2A NKAP BRD1 DEK C8orf33 MARCKS	1.63e-04	510	115	11	int:KAT6A
Interaction	RPL18 interactions	FOXO1 RPL24 MAP3K14 REST LYAR ECT2 CTCF PA2G4 DDX18 EIF4B RPL6	1.68e-04	512	115	11	int:RPL18
Interaction	EPB41L3 interactions	LYAR PPIG MLLT3 BOD1L1 NKAP MARCKS RBFA HDAC1	1.69e-04	272	115	8	int:EPB41L3
Interaction	MDK interactions	PPIG MLLT3 BOD1L1 NKAP RBFA	1.74e-04	91	115	5	int:MDK
Interaction	RPS9 interactions	RPL24 CCDC137 REST LYAR ECT2 CTCF DDX18 EIF4B KMT2A RPL6 MARCKS	1.77e-04	515	115	11	int:RPS9
Interaction	H2BC15 interactions	CYLC1 RPL24 PCLO REST EIF4B H1-6	1.78e-04	144	115	6	int:H2BC15
Interaction	RPL10 interactions	RPL24 CCDC137 MAP3K14 REST LYAR ECT2 CTCF PA2G4 DDX18 NEMF BRD1 DEK RPL6	1.86e-04	702	115	13	int:RPL10
Interaction	KPNA2 interactions	FOXO1 ING1 REST LYAR ECT2 SRRT CTCF BOD1L1 BRD1 MARCKS HDAC1	1.89e-04	519	115	11	int:KPNA2
Interaction	PCM1 interactions	FILIP1 EPS8 RBM11 MYCBP2 FAM81B KIF1B TTC3 SECISBP2 BRD1 HDAC1	1.93e-04	434	115	10	int:PCM1
Interaction	CSNK2A2 interactions	DIS3L2 NEIL1 KIF1B DGKZ LYAR TTC3 EHMT1 KMT2A NKAP NKAPL DEK FKBP3 HDAC1	2.31e-04	718	115	13	int:CSNK2A2
Interaction	RPL34 interactions	RPL24 MAP3K14 REST ECT2 CTCF RPL6 C8orf33 MARCKS	2.32e-04	285	115	8	int:RPL34
Interaction	CSNK2B interactions	EPS8 NEIL1 DGKZ CLOCK PHF2 CTCF EHMT1 KMT2A NKAP DEK FKBP3 HDAC1	2.39e-04	625	115	12	int:CSNK2B
Interaction	H2BC9 interactions	CYLC1 PCLO DGKD SRSF11 REST FSIP2 EIF4B H1-6 DEK FGD6	2.40e-04	446	115	10	int:H2BC9
Interaction	YWHAG interactions	FOXO1 ING1 MYCBP2 KIF1B SRSF11 CDC14A PPIG ALMS1 RHPN2 CLMN EIF4B KMT2A AFDN BOD1L1 NKAP BRD1 FGD6 GAREM1	2.45e-04	1248	115	18	int:YWHAG
Interaction	TFAP4 interactions	PARP2 TOPBP1 CLOCK CTCF EHMT1 HDAC1	2.47e-04	153	115	6	int:TFAP4
Interaction	H3-4 interactions	PARP2 HMGXB4 NSD3 PHF2 H1-6 EHMT1 KMT2A BRD1 DEK HDAC1	2.48e-04	448	115	10	int:H3-4
Interaction	ZBTB2 interactions	LYAR PPIG CTCF DDX18 EHMT1 BRD1 FKBP3 RPL6 MARCKS HDAC1	2.57e-04	450	115	10	int:ZBTB2
Interaction	HNRNPU interactions	RPL24 CCDC137 SRSF11 REST LYAR ECT2 PHF2 CTCF PLCH2 DDX18 EIF4B FGD6 FKBP3 RPL6 MARCKS HDAC1	2.61e-04	1035	115	16	int:HNRNPU
Interaction	MYCN interactions	RPL24 DIS3L2 CCDC137 HMGXB4 SRSF11 UPF3B LYAR SRRT PPIG CTCF DDX18 H1-6 KMT2A NKAP DEK RPL6 C8orf33 MARCKS HDAC1	2.74e-04	1373	115	19	int:MYCN
Interaction	SLFN11 interactions	FILIP1 SETX ECT2 PHF2 EIF4B LTN1 H1-6 BRD1 HDAC1	3.08e-04	376	115	9	int:SLFN11
Interaction	AATF interactions	MYCBP2 NEIL1 ECT2 SRRT PA2G4 DDX18 EIF4B UTP20 RPL6	3.08e-04	376	115	9	int:AATF
Interaction	EPB41L5 interactions	NEIL1 IMPACT LYAR ECT2 MLLT3 AFDN BOD1L1 MARCKS	3.13e-04	298	115	8	int:EPB41L5
Interaction	SMARCA4 interactions	FOXO1 ING1 TOPBP1 REST TTC3 NSD3 CTCF DEK MRTFA HDAC1	3.17e-04	462	115	10	int:SMARCA4
Interaction	MYBBP1A interactions	CCDC137 MYCBP2 NEIL1 LYAR TTF1 CTCF H1-6 RPL6 C8orf33 HDAC1	3.23e-04	463	115	10	int:MYBBP1A
Interaction	CBX3 interactions	RPL24 ATAD5 HMGXB4 TOPBP1 REST NSD3 ZNF518A SRRT EHMT1 KMT2A BRD1 DEK	3.23e-04	646	115	12	int:CBX3
Interaction	SRP68 interactions	RPL24 CCDC137 NEIL1 LYAR ECT2 CTCF PA2G4 RPL6 C8orf33	3.39e-04	381	115	9	int:SRP68
Cytoband	13q33.1	BIVM CCDC168	4.11e-04	12	116	2	13q33.1
Cytoband	1p36.2	KIF1B PIK3CD	4.85e-04	13	116	2	1p36.2
GeneFamily	PHD finger proteins	ING1 NSD3 PHF2 KMT2A BRD1	2.07e-05	90	67	5	88
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	NSD3 EHMT1 KMT2A	2.68e-04	34	67	3	487
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKZ DGKD	5.97e-04	10	67	2	1178
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	KIF1B DGKD RTKN2 ARHGAP12 FGD6	9.96e-04	206	67	5	682
GeneFamily	ATP binding cassette subfamily A	ABCA9 ABCA6	1.20e-03	14	67	2	805
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PCLO LYAR	1.38e-03	15	67	2	26
GeneFamily	PWWP domain containing	NSD3 BRD1	2.98e-03	22	67	2	1147
Coexpression	GSE17721_12H_VS_24H_POLYIC_BMDC_DN	FOXO1 CCDC137 DGKZ SRSF11 ARMCX5 PHF2 CTCF DDX18 MRTFA	2.76e-07	200	116	9	M4102
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP	EPS8 SANBR TOPBP1 ECT2 ZNF518A RTKN2 KMT2A DEK	2.50e-06	194	116	8	M7467
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EPS8 SETX MYCBP2 HMGXB4 MAP3K14 TOPBP1 CLOCK FAM193A CTCF ARHGAP12 LTN1 UTP20 DEK MRTFA LRRFIP1	5.81e-06	856	116	15	M4500
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	FOXO1 RPL24 CDV3 SETX MYCBP2 REST CDC14A EPG5 PPIG CD2 CTCF PIK3CD EIF4B NEMF KMT2A SECISBP2 BOD1L1 DEK RPL6 LRRFIP1	8.33e-06	1492	116	20	M40023
Coexpression	GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP	UPF3B CLOCK CD2 BTBD7 FAM217B MLLT3 FKBP3	3.13e-05	200	116	7	M8495
Coexpression	GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN	RBM11 KIF1B IMPACT CYP39A1 CRACDL MLLT3 MARCKS	3.13e-05	200	116	7	M5724
Coexpression	PUJANA_CHEK2_PCC_NETWORK	CDV3 PARP2 TOPBP1 SRSF11 TTF1 PPIG CTCF PA2G4 DDX18 UTP20 DEK RPL6 HDAC1	3.31e-05	761	116	13	M11961
Coexpression	BUSSLINGER_DUODENAL_IMMUNE_CELLS	FOXO1 RPL24 CDV3 SETX MYCBP2 REST PPIG CD2 PIK3CD EIF4B KMT2A DEK RPL6 LRRFIP1	5.14e-05	911	116	14	M40038
Coexpression	GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN	CDV3 OFCC1 TOPBP1 PA2G4 H1-6 HDAC1	1.12e-04	170	116	6	M6747
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	CDV3 SANBR SRSF11 CLOCK CTTNBP2NL NEMF LTN1 MLLT3 DEK FKBP3	1.13e-04	523	116	10	M12707
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	CDV3 SANBR SRSF11 CLOCK CTTNBP2NL NEMF LTN1 MLLT3 DEK FKBP3	1.34e-04	534	116	10	MM1054
Coexpression	HOSHIDA_LIVER_CANCER_SUBCLASS_S2	RPL24 TTC3 DDX18 EIF4B DEK	1.62e-04	115	116	5	M7995
Coexpression	GEORGES_TARGETS_OF_MIR192_AND_MIR215	EPS8 ATAD5 BIVM SANBR TOPBP1 SLCO3A1 ECT2 CDC14A NSD3 RTKN2 CTCF DEK LRRFIP1	1.64e-04	892	116	13	M18120
Coexpression	ALONSO_METASTASIS_DN	FOXO1 REST SECISBP2	2.04e-04	26	116	3	M17331
Coexpression	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN	FOXO1 NEIL1 DGKD ECT2 PIK3CD BAHCC1	2.24e-04	193	116	6	M6903
Coexpression	GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	SLCO3A1 TTF1 CLOCK ZNF518A ELF4 LRRFIP1	2.30e-04	194	116	6	M6493
Coexpression	GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	ATAD5 ALMS1 C8orf33 LRRFIP1 HDAC1 MYBPC2	2.36e-04	195	116	6	M3467
Coexpression	GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN	SETX PHF2 ABCA6 CTCF BTBD7 ACSL5	2.36e-04	195	116	6	M7382
Coexpression	GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP	SETX IMPACT DGKD PIK3CD DEK GAREM1	2.43e-04	196	116	6	M3243
Coexpression	GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN	MAP3K14 REST CTCF PIK3CD KMT2A MRTFA	2.50e-04	197	116	6	M5877
Coexpression	GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP	RPL24 IMPACT CD2 CRACDL DDX18 RPL6	2.57e-04	198	116	6	M5584
Coexpression	GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN	PCLO KIF1B KMT2A MLLT3 PLK3 LRRFIP1	2.57e-04	198	116	6	M5545
Coexpression	GSE17721_POLYIC_VS_CPG_24H_BMDC_UP	PARP2 MAP3K14 ARMCX5 CTCF SECISBP2 MARCKS	2.57e-04	198	116	6	M3953
Coexpression	GSE11057_CD4_CENT_MEM_VS_PBMC_UP	DIS3L2 MAP3K14 CD2 KMT2A MLLT3 RBFA	2.57e-04	198	116	6	M3116
Coexpression	GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP	EPS8 MYCBP2 NEIL1 DGKZ NKAPL MRTFA	2.64e-04	199	116	6	M9850
Coexpression	GSE22886_NAIVE_TCELL_VS_DC_UP	ING1 MYCBP2 DGKD EIF4B KMT2A RPL6	2.64e-04	199	116	6	M4475
Coexpression	GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	HMGXB4 ECT2 TTF1 CDC14A CTCF KMT2A	2.64e-04	199	116	6	M3070
Coexpression	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	ING1 UPF3B CLOCK CTCF KMT2A	2.67e-04	128	116	5	M4925
Coexpression	GSE40655_FOXO1_KO_VS_WT_NTREG_UP	MYCBP2 CTCF PIK3CD CRACDL DDX18 BOD1L1	2.71e-04	200	116	6	M9439
Coexpression	GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP	PCLO TOPBP1 ECT2 ZKSCAN5 PIK3CD SECISBP2	2.71e-04	200	116	6	M7674
Coexpression	GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN	MAP3K14 CTCF PIK3CD KMT2A BOD1L1 MRTFA	2.71e-04	200	116	6	M5851
Coexpression	GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN	RPL24 HMGXB4 TOPBP1 CTCF DEK RPL6	2.71e-04	200	116	6	M9552
Coexpression	GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN	GRIPAP1 SRSF11 REST NSD3 PLK3 MYBPC2	2.71e-04	200	116	6	M7859
Coexpression	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP	SETX MYCBP2 SLCO3A1 EIF4B FAM217B FGD6	2.71e-04	200	116	6	M8644
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN	TOPBP1 ABCB4 CLMN EIF4B LTN1 HDAC1	2.71e-04	200	116	6	M4066
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_DC_UP	DGKD CD2 EIF4B KMT2A MLLT3 RPL6	2.71e-04	200	116	6	M4490
Coexpression	GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN	CDV3 PCLO LYAR SECISBP2 PLK3 RBFA	2.71e-04	200	116	6	M7376
Coexpression	YANAGIHARA_ESX1_TARGETS	PCLO SRSF11 MARCKS	2.84e-04	29	116	3	M1538
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN	SLCO3A1 CLOCK KMT2A ELF4	2.97e-04	72	116	4	M40882
Coexpression	TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING	RPL24 ING1 DGKZ SRSF11 LYAR CLOCK NSD3 PPIG CTCF BRD1 DEK RPL6 C8orf33 LRRFIP1	3.26e-04	1088	116	14	MM3699
Coexpression	STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	ING1 UPF3B CLOCK CTCF KMT2A	3.30e-04	134	116	5	MM748
Coexpression	GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	CYLC1 GRIPAP1 CD2 EHMT1 NKAPL	3.30e-04	134	116	5	M455
Coexpression	ZHONG_PFC_C3_ASTROCYTE	SETX NEXMIF PCLO SLCO3A1 CTTNBP2NL KMT2A AFDN SRRM3	3.45e-04	389	116	8	M39102
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	EPS8 PCLO IMPACT SLCO3A1 REST TTC3 STAC KMT2A MLLT3 MARCKS LRRFIP1	3.63e-04	721	116	11	M1999
Coexpression	FISCHER_DREAM_TARGETS	ING1 ATAD5 PARP2 HMGXB4 TOPBP1 ECT2 TTF1 ZNF518A RTKN2 ALMS1 CTCF DEK MARCKS	3.64e-04	969	116	13	M149
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	MYCBP2 STXBP5 PCLO BIVM SLCO3A1 TTC3 FSIP2 CD2 PIK3CD FAM217B MLLT3 BOD1L1 BRD1 SRRM3	3.85e-04	1106	116	14	M39071
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	ATAD5 UPF3B LYAR ZNF518A PPIG FAM193A ALMS1 NEMF MLLT3 BOD1L1 DEK FGD6	1.39e-07	311	116	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	ATAD5 STXBP5 PCLO SANBR MYNN UPF3B LYAR ZNF518A PPIG FAM193A ALMS1 BTBD7 NEMF MLLT3 BOD1L1 NKAP DEK MRTFA	5.90e-07	831	116	18	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	CDV3 ATAD5 PCLO SANBR SRSF11 UPF3B LYAR ECT2 ZNF518A PPIG FAM193A ALMS1 PLCH2 NEMF UTP20 MLLT3 BOD1L1 DEK FGD6	1.67e-06	989	116	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3	FOXO1 EPS8 NEIL1 DGKD ECT2 SNX29 ABCB4 PHF2 CD2 FGD6	4.85e-05	383	116	10	GSM399448_500
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	ATAD5 KIF1B BIVM SANBR UPF3B TTC3 CYP39A1 ECT2 CDC14A RTKN2 PPIG ALMS1 CTCF ARHGAP12 EHMT1 MLLT3 BOD1L1 BRD1 DEK GAREM1	4.96e-05	1370	116	20	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3	FOXO1 EPS8 ATAD5 NEIL1 DGKD ECT2 SNX29 ABCB4 CRACDL FGD6	6.27e-05	395	116	10	GSM538340_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ATAD5 SANBR LYAR ALMS1 NEMF DEK FGD6	9.00e-05	192	116	7	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	ING1 PCLO PARP2 SANBR ECT2 CLOCK PPIG CTCF SECISBP2 BOD1L1 BRD1 DEK	1.02e-04	595	116	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	KIF1B BIVM SRSF11 CYP39A1 CDC14A ARHGAP12 EHMT1 SRRM3 PLK3	1.31e-04	350	116	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	SETX ATAD5 SANBR SRSF11 UPF3B LYAR TTF1 CDC14A PPIG FAM193A ALMS1 NEMF UTP20 BOD1L1 BRD1 DEK FKBP3 MARCKS	1.58e-04	1257	116	18	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	SETX ATAD5 PCLO SANBR LYAR TTC3 ZNF518A ALMS1 NEMF MLLT3 FKBP3	1.62e-04	532	116	11	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	SETX ATAD5 NEXMIF SANBR UPF3B LYAR ECT2 TTF1 CDC14A RTKN2 PPIG ALMS1 PIK3CD BOD1L1 BRD1 DEK	2.10e-04	1060	116	16	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	FILIP1 SETX ATAD5 NEXMIF SANBR UPF3B LYAR ECT2 TTF1 CDC14A RTKN2 PPIG ALMS1 PIK3CD PLCH2 BOD1L1 BRD1 DEK PLK3	2.30e-04	1414	116	19	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	MYCBP2 ATAD5 TOPBP1 SRSF11 REST LYAR ZKSCAN5 PPIG BRD1 DEK FGD6	2.67e-04	564	116	11	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	CDV3 ATAD5 PCLO SANBR SRSF11 LYAR CYP39A1 ZKSCAN5 CTTNBP2NL PPIG RHPN2 PLCH2 BOD1L1 DEK FGD6	3.20e-04	989	116	15	Facebase_RNAseq_e10.5_Maxillary Arch_1000
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	EPS8 PCLO REST TTC3 NSD3 PPIG SECISBP2 BOD1L1 DEK LRRFIP1	1.24e-10	199	116	10	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	EPS8 MYCBP2 REST TTC3 PPIG SECISBP2 BOD1L1 NKAP LRRFIP1	2.62e-09	198	116	9	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	EPS8 SETX SLCO3A1 REST TTC3 PPIG RHPN2 SECISBP2 BOD1L1	2.74e-09	199	116	9	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	SRSF11 UPF3B LYAR TTF1 PPIG DDX18 NEMF BOD1L1	4.97e-08	197	116	8	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CDV3 TTC3 NSD3 CLMN DDX18 EIF4B KMT2A	6.54e-07	189	116	7	a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 EPS8 NEIL1 DGKD SNX29 CD2 MARCKS	7.80e-07	194	116	7	11709704079f24a730476572dc2f01e9d2226e2c
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 EPS8 NEIL1 DGKD SNX29 CD2 MARCKS	7.80e-07	194	116	7	3a1f95639d5f239f001bd67d4213e8938e7f299d
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 MYCBP2 PCLO KIF1B TTC3 KMT2A BOD1L1	8.07e-07	195	116	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 MYCBP2 PCLO KIF1B TTC3 KMT2A BOD1L1	8.07e-07	195	116	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLCO3A1 LYAR CDC14A CD2 DDX18 MLLT3 BRD1	8.35e-07	196	116	7	e4c76e7ad68455e51fe93ce588bcec9383f8654b
ToppCell	lymphoid-T_cell\|lymphoid / Lineage, cell class and subclass	CD2 PA2G4 DDX18 EIF4B MLLT3 PLK3 RPL6	8.94e-07	198	116	7	41573038b34803f664a7cb5a7d05b8afdff55b58
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	MYCBP2 SRSF11 TTC3 PPIG PA2G4 DDX18 EIF4B	9.24e-07	199	116	7	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CDV3 SETX MYCBP2 SRSF11 KMT2A BOD1L1 DDX60L	9.56e-07	200	116	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RBM11 LYAR CD2 PIK3CD BOD1L1 RBFA	6.20e-06	173	116	6	79d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCell	IIH-Treg-proli_CD4\|IIH / Condition, Cell_class and T cell subcluster	DIS3L2 SANBR PHF2 RTKN2 ALMS1 ELF4	8.28e-06	182	116	6	5c7d02da9ca2bca49db9832704b6894dfaa08a71
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX MYCBP2 ATAD5 TTC3 CD2 BOD1L1	8.28e-06	182	116	6	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX MYCBP2 ATAD5 TTC3 CD2 BOD1L1	8.28e-06	182	116	6	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 EPS8 NEIL1 CD2 FGD6 MARCKS	8.54e-06	183	116	6	bc24145855bf4d027a8058bf92bc796c10f241bb
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 EPS8 NEIL1 CD2 FGD6 MARCKS	8.54e-06	183	116	6	4c325ee6da070513097a11445ec95b0415ffd8a2
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	SETX PPIG ALMS1 CTCF LTN1 BOD1L1	9.37e-06	186	116	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CDC14A CD2 PA2G4 PIK3CD DDX18 MLLT3	1.09e-05	191	116	6	9bb6a6b88f351217455765ba07a6acf11fda98f4
ToppCell	COPD-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	FOXO1 CTTNBP2NL STAC NSD3 RTKN2 CD2	1.09e-05	191	116	6	3ae18bc4e3dff49b5d5958da8ebc3f747274b69c
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CDC14A CD2 PA2G4 PIK3CD DDX18 MLLT3	1.12e-05	192	116	6	1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6
ToppCell	COVID-19_Severe-CD4+_Tcm\|World / disease group, cell group and cell class	CDC14A NSD3 RTKN2 CD2 EIF4B MLLT3	1.12e-05	192	116	6	3352f13a6e706991dcf3ec173587bb6aba36a385
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NEIL1 DGKD SNX29 BOD1L1 MARCKS LRRFIP1	1.19e-05	194	116	6	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon\|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type.	GPR22 PCLO HMGXB4 NSD3 EIF4B RPL6	1.19e-05	194	116	6	4903a0d6e36599bcb83b179462e5b949df9eb685
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FOXO1 MYCBP2 TTC3 CDC14A CD2 KMT2A	1.23e-05	195	116	6	4b9663509cc5e3f409f6d0d37640cb301a827d98
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NEIL1 DGKD SNX29 BOD1L1 MARCKS LRRFIP1	1.23e-05	195	116	6	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NEIL1 DGKD SNX29 BOD1L1 MARCKS LRRFIP1	1.23e-05	195	116	6	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	FOXO1 SRSF11 TTC3 EIF4B KMT2A MLLT3	1.30e-05	197	116	6	836dd8110d5689f944ad1d301def38c32278b5b5
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	SETX SLCO3A1 REST TTC3 BOD1L1 LRRFIP1	1.38e-05	199	116	6	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	Influenza-Influenza_Severe-Lymphocyte-T/NK-NK_CD56bright\|Influenza_Severe / Disease, condition lineage and cell class	ATAD5 NEIL1 MYNN CLOCK PLCH2 NKAPL	1.38e-05	199	116	6	784e7e7ede2baa28ede600834813e6de2240bfdf
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	EPS8 REST TTC3 NSD3 BOD1L1 LRRFIP1	1.38e-05	199	116	6	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	EPS8 SETX REST TTC3 PPIG BOD1L1	1.38e-05	199	116	6	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	EPS8 REST TTC3 PPIG RHPN2 BOD1L1	1.38e-05	199	116	6	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	GPR22 MYCBP2 PCLO TTC3 AFDN SRRM3	1.38e-05	199	116	6	77b4aa00f14b86ef5db0490be98787e063979541
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	REST TTC3 NSD3 PPIG BOD1L1 FKBP3	1.38e-05	199	116	6	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	RPL24 PCLO TTC3 FSIP2 LTN1 SRRM3	1.41e-05	200	116	6	ac0e023dbb383bbc46c5cc525431778be8f7ef46
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	REST PPIG NEMF BOD1L1 LRRFIP1	3.08e-05	138	116	5	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FOXO1 DGKZ RTKN2 DDX18 MLLT3	4.59e-05	150	116	5	c922dbb4c9c12ccf08bd5f6168b20606c605d052
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	CDC14A CD2 KMT2A MLLT3 BRD1	4.74e-05	151	116	5	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D2\|343B / Donor, Lineage, Cell class and subclass (all cells)	NEIL1 DGKZ CD2 PLCH2 LTN1	5.04e-05	153	116	5	0b3b199678d4a70b0590393568c69454bece5c14
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4\|TCGA-Colorectal / Sample_Type by Project: Shred V9	GRIPAP1 DIS3L2 LYAR PA2G4 RPL6	7.42e-05	166	116	5	52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP39A1 CTTNBP2NL UTP20 NKAPL MARCKS	7.85e-05	168	116	5	d69452e2cfeb74023b5cf3d09064d7dcad0008ec
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATAD5 NEXMIF ECT2 ZKSCAN5 ALMS1	7.85e-05	168	116	5	08f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|Myeloid_cells / Location, Cell class and cell subclass	STXBP5 KIF1B STYXL2 ZKSCAN5 LTN1	8.07e-05	169	116	5	dba8f5599aa21feef5b7fdfed2e3ab54748d80f7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PARP2 IMPACT MYNN STAC CD2	9.01e-05	173	116	5	506efcaa5afd6ed5e565c4c4def6a4505fea97c5
ToppCell	10x3'2.3-week_17-19-Lymphocytic_T-T_NK-Treg\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MAP3K14 FSIP2 RTKN2 CD2 MLLT3	9.26e-05	174	116	5	7ca39c9ecd609e5ade30dac1a948a4a4fff1b3b2
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1\|TCGA-Liver / Sample_Type by Project: Shred V9	SLCO3A1 CCDC160 CTTNBP2NL MLLT3 ELF4	1.03e-04	178	116	5	51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	FOXO1 DGKD SNX29 ABCB4 MYBPC2	1.03e-04	178	116	5	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	URO-Lymphocyte-T_NK-CD4_TCM\|URO / Disease, Lineage and Cell Type	CDC14A RTKN2 CD2 PA2G4 RPL6	1.06e-04	179	116	5	cdf972acf23c7a22c99a336ee0f9cc51e0fa6f67
ToppCell	COPD-Lymphoid-T_Regulatory\|World / Disease state, Lineage and Cell class	FOXO1 CDC14A NSD3 RTKN2 CD2	1.09e-04	180	116	5	51a12fbad5fa7bb12e6d616a02ff9b5141e2b063
ToppCell	Control-Lymphoid-T_Regulatory\|World / Disease state, Lineage and Cell class	FOXO1 CDC14A NSD3 RTKN2 CD2	1.09e-04	180	116	5	47036eee4c128fbb443d1fc767b4de5cced93f0e
ToppCell	B_cells-Naive_B_cells_\|World / Immune cells in Kidney/Urine in Lupus Nephritis	NEIL1 DGKD SNX29 ABCB4 MYBPC2	1.14e-04	182	116	5	63c3b63315276b66667d49fab09661ac320e7a36
ToppCell	Control-Lymphoid-T_Regulatory\|Control / Disease state, Lineage and Cell class	FOXO1 CDC14A NSD3 RTKN2 CD2	1.14e-04	182	116	5	31bb838cc2900f3c9da9f835d79d557a08abb928
ToppCell	(4)_B_cells-(4)_B_mantle\|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	NEIL1 DGKD SNX29 NSD3 RPL6	1.17e-04	183	116	5	21b7fb6482eb1d5d31a4029e47e0992e8ddc8e2c
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLCO3A1 CDC14A CD2 DDX18 MLLT3	1.20e-04	184	116	5	bd786db4dc4edae6d5cfc0b69901983dea19f729
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	NSD3 ZNF518A SECISBP2 AFDN DEK	1.23e-04	185	116	5	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgM_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RPL24 CDV3 DDX18 EHMT1 RPL6	1.23e-04	185	116	5	26ea60b6392410fab048f2e406a9860a018429cc
ToppCell	COPD-Lymphoid-T_Regulatory\|COPD / Disease state, Lineage and Cell class	FOXO1 CDC14A NSD3 RTKN2 CD2	1.23e-04	185	116	5	846403edd4c8f646201d519055198fc38b7ffff9
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX DGKZ DGKD CD2 PIK3CD	1.23e-04	185	116	5	a2cae8c657e4f4d121476798e424876f7e247973
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX DGKZ DGKD CD2 PIK3CD	1.23e-04	185	116	5	d50406a9a5b8d75110ba5985741aa2293950c543
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	FILIP1 KIF1B CLOCK ABCA9 FAM217B	1.27e-04	186	116	5	6259f0f2d5bc863782d09a901d6be2f387d1f074
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 NSD3 PPIG PLK3 LRRFIP1	1.30e-04	187	116	5	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FOXO1 FILIP1 SANBR CLOCK KMT2A	1.33e-04	188	116	5	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FOXO1 FILIP1 SANBR CLOCK KMT2A	1.33e-04	188	116	5	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FOXO1 FILIP1 SANBR CLOCK KMT2A	1.33e-04	188	116	5	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-Tregs\|Lung / Manually curated celltypes from each tissue	FOXO1 CDC14A NSD3 RTKN2 CD2	1.33e-04	188	116	5	604f340052807bd902915eca942a97ccc36b42e0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NEIL1 SNX29 BOD1L1 MARCKS LRRFIP1	1.36e-04	189	116	5	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 EPS8 NEIL1 DGKD MARCKS	1.43e-04	191	116	5	318323a12029a7992f16382cb0c186f5b2e1ca47
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MYCBP2 IMPACT UPF3B TTC3 SRRM3	1.43e-04	191	116	5	5d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCell	Entopeduncular-Neuronal-Inhibitory\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MYCBP2 IMPACT UPF3B TTC3 SRRM3	1.43e-04	191	116	5	73dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 EPS8 NEIL1 DGKD MARCKS	1.43e-04	191	116	5	4aa29337f4d2528577bb90dc4abfb6eab93e120f
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-IPC_like-IPCs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	RPL24 PLCH2 MLLT3 AFDN RPL6	1.47e-04	192	116	5	bd91bf0ceeac49dc5a18aa2e401244db0ca596ae
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RBM11 CDC14A CD2 MLLT3 RPL6	1.47e-04	192	116	5	78546a6e077076834fd717607610ab6df3b6e7ba
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MAP3K14 DGKD PLK3 MRTFA LRRFIP1	1.47e-04	192	116	5	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4\|Lung / Manually curated celltypes from each tissue	FOXO1 CDC14A NSD3 CD2 KMT2A	1.47e-04	192	116	5	fd19cd0b5330448bef8debd753285adbc8b958a2
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-IPC_like\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	RPL24 PLCH2 MLLT3 AFDN RPL6	1.47e-04	192	116	5	18fbf485ad762ba7a9ac3e19bad136b0cf3af3c5
ToppCell	Mild/Remission-B_naive-11\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RPL24 EPS8 SNX29 NSD3 RPL6	1.47e-04	192	116	5	c6f325cddce43b72f013b21dfffc9987fd68b6a7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PCLO SNX29 RHPN2 CLMN GAREM1	1.50e-04	193	116	5	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	FOXO1 EPS8 ABCA9 ABCA6 MRTFA	1.54e-04	194	116	5	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 EPS8 NEIL1 CD2 MARCKS	1.54e-04	194	116	5	ad1aacff97beb76f4211942676e1d5e84087d44e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PCLO SNX29 RHPN2 CLMN GAREM1	1.54e-04	194	116	5	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 EPS8 NEIL1 DGKD MARCKS	1.54e-04	194	116	5	7ee8ac172c2dee7df7dc4eb222e0985a0089bda8
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXO1 EPS8 NEIL1 CD2 MARCKS	1.54e-04	194	116	5	fdd59b1e036b2d6d8877e1a920a0e56a91a2a882
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLCO3A1 CDC14A CD2 DDX18 MLLT3	1.54e-04	194	116	5	a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RPL24 CDC14A CD2 MLLT3 RPL6	1.58e-04	195	116	5	4e114f6399863406bd87220dea7fb7dfd08824bd
ToppCell	COVID-19_Mild-Lymphoid_T/NK-CD4+_T_naive\|COVID-19_Mild / Disease group, lineage and cell class	RPL24 CDC14A CD2 EIF4B MLLT3	1.58e-04	195	116	5	8aec807b24bcebf1a8011d676d2143b6fc570f1d
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RPL24 CDC14A CD2 EIF4B MLLT3	1.58e-04	195	116	5	d9965223430aba1ec0b1b77b5bd40d3a01e42e95
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RPL24 CDC14A CD2 EIF4B MLLT3	1.58e-04	195	116	5	d056c806c7ad38ca425bdaa44385424a7f43f915
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CDC14A STAC RTKN2 CD2 CRACDL	1.58e-04	195	116	5	d70b49f6b9c6c4422adb2936c837a1af7569fb0a
ToppCell	COVID-19_Moderate-CD4+_T_naive\|World / disease group, cell group and cell class	RPL24 CDC14A NSD3 CD2 MLLT3	1.58e-04	195	116	5	38d65cf0895f7a99d789ec3dcbd56a7506706d38
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	FOXO1 EPS8 ABCA9 ABCA6 MRTFA	1.58e-04	195	116	5	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	FOXO1 EPS8 ABCA9 ABCA6 MRTFA	1.58e-04	195	116	5	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RPL24 CDC14A CD2 EIF4B MLLT3	1.58e-04	195	116	5	1d3c51a3be5ad1fbc465c5f684565ec4c6f35f54
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	FOXO1 CDC14A RTKN2 CD2 KMT2A	1.58e-04	195	116	5	22191d361af136942508f1553ff41a626ed982ad
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAM81B CLMN CRACDL PPP1R42 FYB2	1.58e-04	195	116	5	9651ee03738226ee10e901f8b9ec6a417eb9c301
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_reg-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL24 NSD3 RTKN2 CD2 RPL6	1.58e-04	195	116	5	911a37684c1f93d537f51ee71cb1ccec06840315
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	RPL24 CDC14A CD2 EIF4B MLLT3	1.58e-04	195	116	5	6421d949bfebcd985bea7efc5731a1ca79350b61
ToppCell	Severe-B_naive-2\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RPL24 NEIL1 NSD3 RPL6 LRRFIP1	1.62e-04	196	116	5	8ed9784684de0a31e4d20a79486e9b638d5a2605
Drug	GW8510; Down 200; 10uM; MCF7; HT_HG-U133A	SETX ING1 PARP2 HMGXB4 ARMCX5 TTF1 FAM193A ARHGAP12	5.32e-06	187	116	8	7080_DN
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A	SETX ATAD5 IMPACT SLCO3A1 REST CDC14A ALMS1 ELF4	7.79e-06	197	116	8	3411_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	ING1 NSD3 SRRT ALMS1 BTBD7 SECISBP2 ELF4 FGD6	7.79e-06	197	116	8	6934_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CYLC1 ATAD5 IMPACT ALMS1 ELF4 MARCKS LRRFIP1 GAREM1	8.09e-06	198	116	8	7177_DN
Disease	breast carcinoma (is_marker_for)	CTCF AFDN PLK3 HDAC1	1.14e-04	66	111	4	DOID:3459 (is_marker_for)
Disease	autism spectrum disorder (is_marker_for)	SRSF11 EIF4B	2.91e-04	7	111	2	DOID:0060041 (is_marker_for)
Disease	Nephroblastoma	DIS3L2 REST CTCF	3.38e-04	36	111	3	C0027708
Disease	nephroblastoma (is_implicated_in)	DIS3L2 REST	1.24e-03	14	111	2	DOID:2154 (is_implicated_in)
Disease	N-acetylmethionine measurement	SLCO3A1 ALMS1	1.43e-03	15	111	2	EFO_0021427
Disease	serum dimethylarginine measurement	OFCC1 SLCO3A1 SNX29	1.75e-03	63	111	3	EFO_0005418
Disease	MAJOR AFFECTIVE DISORDER 2	HMGXB4 IMPACT	1.84e-03	17	111	2	C1839839
Disease	Schizophrenia	CCDC137 OFCC1 REST CLOCK RTKN2 CTCF KMT2A BRD1 NKAPL HDAC1	1.86e-03	883	111	10	C0036341
Disease	disease free survival	OFCC1 CCDC168	2.06e-03	18	111	2	EFO_0000409
Disease	Bipolar Disorder	PCLO HMGXB4 IMPACT CLOCK SRRT MLLT3 BRD1	2.21e-03	477	111	7	C0005586
Disease	Major Depressive Disorder	PCLO REST CLOCK SRRT EIF4B	2.29e-03	243	111	5	C1269683
Disease	Malignant neoplasm of breast	TTC3 ECT2 EPG5 CD2 DDX18 FAM217B EHMT1 UTP20 BOD1L1 DEK LRRFIP1	2.43e-03	1074	111	11	C0006142
Disease	corneal hysteresis	FOXO1 ABCA6	2.55e-03	20	111	2	EFO_0010066
Disease	venous thromboembolism, tissue plasminogen activator measurement	STXBP5 DGKZ	3.37e-03	23	111	2	EFO_0004286, EFO_0004791

Protein segments in the cluster

Peptide	Gene	Start	Entry
LKGFKESNSTKKKSK	TTF1	376	Q15361
ESNSTKKKSKKRKLT	TTF1	381	Q15361
NFKRTLSKKEKKEKK	AFDN	156	P55196
EKSEQKKAKKAFQKR	CCDC137	156	Q6PK04
KKSKKKSNKRSEKSE	ATAD5	666	Q96QE3
KSQVKKFEKEQKKLS	CTTNBP2NL	151	Q9P2B4
AKAKASRTKTKEKKK	EPG5	11	Q9HCE0
RSTSKVRKKAKKAKK	BRD1	421	O95696
SKSKLKRKEALSFSK	BAHCC1	2441	Q9P281
AKKTKKTKKSKLRYT	CTCF	201	P49711
TASKKQKNKKKTRNR	C8orf33	66	Q9H7E9
KLNKKLKSYSLSRKK	CDC14A	66	Q9UNH5
KKNCFSKRKKKIATR	ABCA9	1296	Q8IUA7
KKRKKSSSEALFKSF	MLLT3	296	P42568
KTSDKKKIAQFRKEK	CD2	61	P06729
KSCFSKRKKKIAARN	ABCA6	1291	Q8N139
NKLQKKKRFKSLEKS	ALMS1	3671	Q8TCU4
NAKKQVSKRKTSDKK	BIVM	161	Q86UB2
KSKNRSTRGKKKSIF	DIS3L2	36	Q8IYB7
NFFAKRDKKKKKERS	CDV3	11	Q9UKY7
SDSKEKKNAAKKKCL	FAM193A	581	P78312
KTKAKLFTKEKFTKS	ARMCX5	506	Q6P1M9
CKNWLKKFASKTKKK	RBFA	41	Q8N0V3
NECSQKFRKSKKKKR	RBM11	266	P57052
KKTSKKVTRAFSFSK	ECT2	831	Q9H8V3
KAKEIFQKKFLDKTK	PARP2	171	Q9UGN5
KSSLKSSKKKNGKVR	LTN1	526	O94822
SASRKTQKKKKKKAS	PA2G4	361	Q9UQ80
EKFSKTKKSKRKLEV	REST	511	Q13127
KKSTKKKTLKNKSSK	REST	576	Q13127
KGRKSRKKKSKATQL	NEIL1	291	Q96FI4
KAFKSAEKKTKQTLK	NEMF	496	O60524
RKNSSNFKKAKRVKT	HDAC1	431	Q13547
ESAKKTGKSKKRIRK	ELF4	166	Q99607
AEVDNCTSKSKKKKK	KIF1B	286	O60333
ITKKSKKKSFLKEDQ	DDX60L	566	Q5H9U9
RKKSFKTKDTSVKKG	FSIP2	5471	Q5CZC0
KKDDKLFQLSSLKSK	FSIP2	5621	Q5CZC0
KSSSKKSKKDKDELR	PCLO	1801	Q9Y6V0
TKYTKKDTKKNAKKS	CYLC1	281	P35663
EEKKKKSSKSTKLQR	FAM217B	291	Q9NTX9
KTFKEKSRLNTIFKK	GAREM1	166	Q9H706
ALAKKSSQTKKKKKA	MYNN	171	Q9NPC7
SSQTKKKKKAFNSPK	MYNN	176	Q9NPC7
KTRQNKLAEAKKKFT	GOLGA6L2	16	Q8N9W4
IKDTFKIKFKKNKDT	ANKS4B	201	Q8N8V4
DSYREIKKKKKSKKS	HMGXB4	311	Q9UGU5
QSSNSESKKKKKKKR	DDX18	101	Q9NVP1
SSKALGKNKKVRKDK	IMPACT	301	Q9P2X3
KTFKKFFGKKKRKES	CRACDL	31	Q6NV74
SEQKKTKKNLKKFLT	ARHGAP12	621	Q8IWW6
FELGISSKQKRKKTK	ABCB4	21	P21439
SKVKKEEKKRHKSSS	PPIG	181	Q13427
KVKKRAKSKSRSKSK	PPIG	451	Q13427
KKSQRLFFKNIKSTK	FAM81B	16	Q96LP2
LKQTKQKKSKSAEFL	OFCC1	11	Q8IZS5
FQKAAKKKTKKRDTK	UPF3B	136	Q9BZI7
EEKRKQKAEKTKSSK	BOD1L1	516	Q8NFC6
KSRSLKHSSKDIKKK	BOD1L1	1021	Q8NFC6
SKFAKSRSRAAKKKA	FOXO1	261	Q12778
RSKAKKSVSAKTKKL	H1-6	121	P22492
SKSPKTAKTNKRAKK	H1-6	141	P22492
RKLKKKAKKVASVDS	CUSTOS	191	Q96C57
SKSKKSVKSANVKKA	DEK	271	P35659
TSAKKKKNAKPLSFK	FKBP3	151	Q00688
SSRKFQEESKFKRKK	CCDC160	51	A6NGH7
KKFLLKLAVSSKFKE	ACSL5	371	Q9ULC5
KKKRTSGLATLKKKF	BTBD7	56	Q9P203
KKSFKLSGFSFKKNK	MARCKS	161	P29966
GKRSKKKKQRKDSAS	LYAR	246	Q9NX58
KFRLVTKFKKEKNNK	DGKD	1116	Q16760
RQKGKKSCKETFKEK	KMT2A	2426	Q03164
KFKALKSFFVKKKEK	KIAA1210	166	Q9ULL0
NKSLFSTNKKKIKEF	CYP39A1	176	Q9NYL5
AEAFSELSKRKKNKK	EPS8	291	Q12929
RKKSELDFKTKFKKI	CCDC168	1386	Q8NDH2
KASKKKKRASFKRKS	DGKZ	256	Q13574
FSTGQKKKARKKKTI	GPR22	246	Q99680
EFSKAQKALSKSKKA	GRIPAP1	51	Q4V328
LSSESSIKKKFLKRK	EHMT1	416	Q9H9B1
SIKKKFLKRKGKTDS	EHMT1	421	Q9H9B1
ALDSSQKKTKNKKKK	LRRFIP1	561	Q32MZ4
EKKKKSSRSKERSKK	NKAP	181	Q8N5F7
KKKNKKGKTISLTDF	EIF4B	6	P23588
KARKKRKKKSSKSLA	MAP3K14	141	Q99558
KKLAKKLKTSISKAT	RTKN2	191	Q8IZC4
SKTTISAEKVKKKKN	UTP20	1311	O75691
SRSSKCKRKEKNKEK	SRRM3	226	A6NNA2
NVSADAKCKKERKKK	SNX29	246	Q8TEQ0
EQKSKKKKSAKRKLT	PHF2	946	O75151
NKKKKKKVSCFSNIK	SLCO3A1	26	Q9UIG8
SLSEDAKKKKKSNRK	FILIP1	31	Q7Z7B0
TSKKKKRSKAKAERE	ING1	326	Q9UK53
KFKSEARLKSKKVKA	NEXMIF	721	Q5QGS0
FKIKKTKSKENLSAF	FYB2	556	Q5VWT5
KDAKKISKKRSSKNE	PPP1R42	246	Q7Z4L9
AKKAAAIRAKKSSKV	SIGLECL1	146	Q8N7X8
ALAKTSKRKTKVQKD	SETX	771	Q7Z333
EASRKNKKKKEKSTS	SECISBP2	376	Q96T21
LKRKQKSKSKVKTRS	MYCBP2	111	O75592
KKDKFKSKLFCKKIE	SANBR	291	Q6NSI8
NFIEKVKTKSRKFSK	STXBP5	731	Q5T5C0
DKTDKTKKISKKLSF	RHPN2	626	Q8IUC4
ASEKSQRSKKAKELK	MRTFA	216	Q969V6
LIKAKSTKCFDKKLK	SMCR8	306	Q8TEV9
SEKEAKKSSKKRNRK	SRRT	341	Q9BXP5
TKESISSKKKEKRKH	CLMN	856	Q96JQ2
KDKAKRVSRNKSEKK	CLOCK	31	O15516
SRSRNKKKRKNKSSK	NKAPL	181	Q5M9Q1
KVTKSLFGRKKKSKN	PLK3	346	Q9H4B4
AAKEAKKAKQASKKT	RPL24	111	P83731
RKYSAAKSKVEKKKK	RPL6	71	Q02878
RERSTSKKKKSKDKE	SRSF11	391	Q05519
SRRKKKGSKLKKAAS	PLCH2	581	O75038
SDNKRSSLFKKKKVK	STYXL2	861	Q5VZP5
SKLQKLKRSLSFKTK	STAC	36	Q99469
KPCKDSTKKNSFKKL	FGD6	616	Q6ZV73
KSLKKKIKKVSNASE	TTC3	1571	P53804
AVIEKAKKARSTKKK	PIK3CD	396	O00329
AKKARSTKKKSKKAD	PIK3CD	401	O00329
NRKKTSKKIFSKTKT	ZNF518A	1246	Q6AHZ1
TKSKHESRKEKRKKS	NSD3	186	Q9BZ95
KRKTAKKQKLSVKEC	NPIPB2	156	A6NJ64
KAALLKKKNSSFSKK	TOPBP1	461	Q92547
SDKRSKNTKLSVKKK	ZKSCAN5	461	Q9Y2L8
KKAKVEVKKSAAFTK	MYBPC2	246	Q14324